Enhance.MD

Enhance.MD

Enhance.MD is a telehealth-based metabolic wellness program offering clinician-directed treatment options for people exploring medically supervised weight management. Its programs include semaglutide, tirzepatide, a semaglutide-and-tirzepatide combination, NAD+ therapy, and lower-dose tirzepatide. The Enhance.MD model brings together medical intake, laboratory testing, provider consultation, prescription management, treatment monitoring, and ongoing support, creating a structured approach to GLP-1 treatment and metabolic wellness.

Check Your Eligibility →

What Is Enhance.MD?

enhance md

Enhance.MD is a patient-management platform supporting telehealth care for metabolic wellness and weight management. Its current treatment lineup includes GLP-1 Core with semaglutide, GLP-1 Advanced with tirzepatide, GLP-1 Elite with semaglutide plus tirzepatide, NAD+ Therapy, and Microdosing Tirzepatide.

The service is designed around more than simply obtaining medication. Its listed care model incorporates provider evaluation, laboratory testing, personalized dose guidance, follow-up support, and medication delivery.

Enhance.MD LLC itself describes its role as providing administrative and operational support to healthcare practices delivering care through telehealth. Clinical decisions, including whether medication should be prescribed, remain with the prescribing provider.

How Enhance.MD’s Telehealth Model Works

Enhance.MD uses a remote-care model that allows patients to complete the major stages of evaluation and treatment without relying exclusively on in-person appointments.

The process is organized around four primary steps:

1. Medical intake
2. Laboratory work
3. Provider consultation
4. Home delivery

The platform also lists personalized dose guidance, provider monitoring, check-ins, ongoing support, and coaching among its program features. Prescription products require an online consultation with a licensed healthcare professional, and completing an intake does not guarantee that a prescription will be issued.

Key Features of Enhance.MD

Key features include:

● Clinician-directed GLP-1 treatment
● Semaglutide and tirzepatide options
● A semaglutide/tirzepatide combination program
● Laboratory screening and monitoring
● Personalized dose guidance
● Provider check-ins
● Telehealth consultations
● Medication delivery
● Coaching and ongoing support
● A flat-price structure across listed doses

The combination of medical oversight and remote access may appeal to people who prefer a telehealth weight-management program.

Understanding GLP-1 and GIP Medications for Weight Management

GLP-1, or glucagon-like peptide-1, is a hormone involved in appetite regulation, glucose metabolism, and digestive processes. GLP-1 receptor agonists can influence appetite and food intake while slowing gastric emptying.

Semaglutide primarily activates the GLP-1 receptor. Tirzepatide works differently by activating both the GLP-1 and GIP receptors. GIP, or glucose-dependent insulinotropic polypeptide, is another hormone involved in metabolic regulation.

These mechanisms help explain why GLP-1 and GIP-based treatments have become important tools in medically supervised weight management. They are prescription medications rather than conventional dietary supplements, and their suitability depends on individual medical factors.


Enhance.MD GLP-1 Core: Semaglutide

GLP-1 Core uses semaglutide and is listed at $212 per month, with the same listed price across doses. The program includes four weeks of medication, provider care and support, and metabolic laboratory testing every six months.

Semaglutide has been extensively studied in adults with overweight or obesity. In the STEP 1 randomized trial, participants receiving once-weekly semaglutide alongside lifestyle intervention experienced substantially greater average weight reduction than those receiving placebo over 68 weeks.

These findings provide evidence for semaglutide as a weight-management medication, but clinical trial averages should never be interpreted as a guarantee for an individual patient. Response, tolerability, health status, and treatment duration can differ.

Enhance.MD GLP-1 Advanced: Tirzepatide

GLP-1 Advanced uses tirzepatide and is listed at $280 per month, with the same listed price across doses. The program includes four weeks of medication, ongoing provider support, and metabolic laboratory testing every six months.

Tirzepatide activates both GLP-1 and GIP receptors, giving it a different pharmacological profile from semaglutide. In the SURMOUNT-1 clinical trial, tirzepatide produced substantial average weight reductions over 72 weeks among adults with obesity who did not have diabetes.

The FDA has also approved tirzepatide under the brand Zepbound for chronic weight management in qualifying adults. That approval should not be confused with compounded tirzepatide formulations, which have different regulatory status.

Enhance.MD GLP-1 Elite: Semaglutide + Tirzepatide

GLP-1 Elite combines semaglutide and tirzepatide and is listed at $322 per month across doses. The program includes four weeks of medication, provider care and support, and metabolic laboratory testing every six months.

Because the program combines two therapies, it should not automatically be interpreted as being appropriate for everyone or as universally more effective than an individual medication.

The clinical suitability of combination treatment depends on the patient's circumstances and the prescribing provider's assessment. Patients should not combine prescription medications independently or modify their treatment without medical guidance.

NAD+ Therapy and Microdosing Tirzepatide

Enhance.MD also offers options outside its primary GLP-1 programs.

NAD+ Therapy is listed at $169 per month and is positioned as a metabolic wellness option involving NAD+ therapy and ongoing provider support. The program describes NAD+ in relation to cellular energy and metabolic wellness, although evidence for specific wellness outcomes should not be interpreted as equivalent to the established clinical evidence for GLP-1 medications.

Microdosing Tirzepatide is listed at $169 per month and uses lower-dose tirzepatide, with the program listing a 1 mg-per-week cap. It is positioned toward long-term metabolic wellness rather than weight loss as the primary objective, with medication described as being shipped every 12 weeks.

enhance md Money Back Guarantee

100% Satisfaction
Enhance.MD Money-Back Guarantee

Enhance.MD describes a 100% money-back guarantee connected specifically to the onboarding process.

If, during onboarding, the provider determines that a patient is ineligible for medication, the program states that a refund will be provided. This should not be interpreted as a general satisfaction guarantee or a promise of weight-loss results.

Benefits of a Clinician-Directed Metabolic Wellness Program

A major potential benefit of medical supervision is the ability to evaluate treatment within the context of a person's overall health rather than focusing exclusively on body weight.

A provider can consider medical history, medications, laboratory findings, potential contraindications, treatment response, and side effects.

Ongoing monitoring can also make it possible to reassess treatment over time. Weight management is rarely a single decision, and individual responses to medication can vary.

Enhance.MD GLP-1 Treatment Options

Compare the Core, Advanced, and Elite programs and understand how their treatment options differ.

enhance md GLP-1
GLP-1 Core

Steady, foundational weight loss​ 

enhance md GLP-1
GLP-1 Advanced

Stronger appetite control, faster momentum​ 

enhance md GLP-1
GLP-1 Elite

Maximum support for challenging plateaus​ 

enhance md
Microdosing Tirzepatide

Long-term metabolic support, greater comfort 

Check Eligibility →

Who May Be a Candidate for Enhance.MD?

Potential candidates are adults seeking medically supervised metabolic or weight-management care who meet the clinical requirements established by their healthcare provider.

Eligibility can depend on medical history, weight-related health factors, medications, laboratory findings, and other considerations.

Meeting a particular weight-loss goal does not automatically make someone eligible for prescription treatment.

Enhance.MD vs. Traditional Dieting and Other Weight-Loss Approaches

Nutrition, physical activity, sleep, and behavioral changes remain important components of healthy weight management.

The difference with a clinician-directed program is that prescription therapy may be incorporated when medically appropriate.

This does not mean medication replaces lifestyle changes. Major semaglutide and tirzepatide trials evaluated treatment alongside lifestyle interventions, reinforcing the role of comprehensive care rather than medication in isolation.

Scientific Evidence Behind GLP-1 and GIP-Based Weight Management

The scientific evidence supporting GLP-1-based weight management is extensive. The STEP 1 trial demonstrated clinically meaningful weight reduction with semaglutide alongside lifestyle intervention over 68 weeks.

Tirzepatide has also demonstrated substantial weight reduction in randomized clinical research. SURMOUNT-1 evaluated three tirzepatide doses over 72 weeks and found significantly greater weight reduction than placebo.

A 2025 head-to-head trial involving adults with obesity but without type 2 diabetes found greater average weight and waist-circumference reductions with tirzepatide than semaglutide over 72 weeks. The results provide useful comparative evidence but do not establish that tirzepatide is the right choice for every patient.

Importantly, evidence about semaglutide and tirzepatide as medications should not be presented as direct clinical evidence that the Enhance.MD program itself produces specific outcomes.

Customer Reviews and Experiences

“So much easier than I expected.”

The online process was surprisingly simple. I could complete the initial steps from home and speak with a provider without having to arrange an in-person visit. That convenience made getting started much less stressful.
“I really liked having professional guidance.”

For me, the biggest advantage was having a healthcare professional involved in the process. It felt better than trying random weight-loss products on my own because my treatment options were reviewed based on my individual situation.
“The home delivery made everything more convenient.”

I have a busy schedule, so having the medication delivered to my home was a major plus. I didn’t have to make extra trips just to manage my program, which made it easier to stay consistent with my routine.

Realistic Expectations: What Patients Should Know Before Starting

GLP-1 treatment should not be viewed as an instant solution.

Clinical studies demonstrate that semaglutide and tirzepatide can produce significant weight reduction in appropriate populations, but individual results vary. In addition, lifestyle habits remain relevant to overall health.

Treatment response can be influenced by adherence, nutrition, physical activity, starting health status, medication tolerance, and duration of treatment.

A more realistic approach is to evaluate progress over time rather than expecting a predetermined amount of weight loss within a fixed period.

Frequently Asked Questions

Enhance.MD offers several clinician-directed programs involving GLP-1 and GIP-based therapies, including semaglutide, tirzepatide, and a combination option.

Listed monthly prices range from $169 to $322, depending on the program. Promotional pricing can change.

No. Enhance.MD identifies its prescription products as compounded medications that are not FDA-approved.

No. Individual outcomes vary. The stated money-back guarantee relates to eligibility during onboarding, not guaranteed weight-loss results.

Yes. Semaglutide is the active medication in the GLP-1 Core program.

Yes. Tirzepatide is offered through GLP-1 Advanced, GLP-1 Elite, and the lower-dose Microdosing Tirzepatide program.

Explore the Enhance.MD Weight Loss Program

Learn more about clinician-directed GLP-1 treatment options, including semaglutide and tirzepatide, with online consultations, laboratory monitoring, and continued provider support.

Get Started Today →

Affiliate Disclaimer: This article may contain affiliate links. If you choose to purchase a product or service through one of these links, we may receive a commission at no additional cost to you. Our editorial content is created to provide helpful and informative information, and affiliate relationships do not influence the information we share or our commitment to presenting products fairly.

Please conduct your own research and consult a qualified healthcare professional before making decisions about prescription medications, GLP-1 treatments, or other health-related services.

© Copyright 2026 Enhance.MD - All Rights Reserved